RE: Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial

Journal of the National Cancer Institute

Volumn 106, Issue 4, 2014, Pages

  El Bayoumy, Karam ^a   Thompson, Henry ^b   Manni, Andrea ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b Veterinary Dentistry and Oral Surgery   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID;

BLOOD; HUMAN; MALE; NOTE; PROSTATE TUMOR;

FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; HUMANS; MALE; PROSTATIC NEOPLASMS;

EID: 84898925477     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/dju017     Document Type: Letter

References (6)

1. Brasky TM, darke AK, Song X, et al. Plasma phospholipid fatty acids and prostate cancer risk in the SElECT Trial. J Natl Cancer Inst. 2013;105(15):1132-1141.
2. Gomolka B, Siegert E, Blossey K, et al. Analysis of omega-3 and omega-6 fatty acid-derived lipid metabolite formation in human and mouse blood samples. Prostaglandins Other Lipid Mediat. 2011;94(3-4):81-87.
3. Sapieha P, Stahl A, Chen J, et al. 5-lipoxygenase metabolite 4-HdHA is a mediator of the antiangiogenic effect of ω-3 polyunsaturated fatty acids. Sci Transl Med. 2011;3(69):69ra12.
4. Zhang G, Panigrahy d, Mahakian lM, et al. Epoxy metabolites of docosahexaenoic acid (dHA) inhibit angiogenesis, tumor growth, and metastasis. Proc Natl Acad Sci USA. 2013;110(16):6530-6535.
5. Simopoulos AP. Genetic variants in the metabolism of omega-6 and omega-3 fatty acids: their role in the determination of nutritional requirements and chronic disease risk. Exp Biol Med (Maywood). 2010;235(7):785-795.
6. Bettaieb A, Nagata N, AbouBechara d, et al. Soluble expoxide hydrolase deficiency or inhibition attenuates diet-induced endoplasmic reticulum stress in liver and adipose tissue. J Biol Chem. 2013;288(20):14189-14199.